roche factor Xa PAGE Pages on BioPortfolio:

BioPortfolio - roche factor Xa PAGE
Roche Drug | roche | roche factor Xa PAGE | Roche | parafrag drug design ... BioPortfolio - roche factor Xa PAGE Recent Search Terms used to find this page: ...
http://www.bioportfolio.com/search/roche__factor_Xa__PAGE.ht...

BioPortfolio - ncbi and drug designing
Roche Drug | roche | roche factor Xa PAGE | Roche | parafrag drug design BioPortfolio ... from the NCBI used on this page NCBI's standard disclaimer applies ...
http://www.bioportfolio.com/search/ncbi_and_drug_designing.h...

BioPortfolio - ASPN - asporin
Endoproteinase AspN · Enterokinase, light chain · Factor Xa Protease . ... Resources from the NCBI used on this page, NCBI's standard disclaimer applies. ...
http://www.bioportfolio.com/gene/54829-ASPN.html...

BioPortfolio Client Press Releases Site Map
Pharmacological activation of transforming growth factor-beta1 (TGF-beta1) ..... Curacyte awarded a €1.2M grant to fund development of Factor Xa inhibitors ...
http://www.bioportfolio.com/news/site_map.htm...

BioPortfolio.com - BioWeb PARATHAR TERIPARATIDE ACETATE 182mg5ml ...
In August 2001, Fabrazyme® was approved in the EU. See Hemophilia B Gene Therapy (3189)- Factor Xa Inhibitor (1291) Factor Xa. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

Results from other life science and pharmaceutical sites:

The discovery of the Factor Xa inhibitor otamixaba...[Curr Med ...
Guertin@Roche.com. Factor Xa (fXa) is a critical serine protease situated at the confluence of the intrinsic and extrinsic pathways of the blood coagulation ...
http://www.ncbi.nlm.nih.gov/pubmed/17979700...

Ancylostoma caninum anticoagulant peptide: a hookworm-derived ...
Roche M, Layrisse M. The nature and causes of "hookworm anemia". ... Ancylostoma factor Xa inhibitor: partial purification and its identification as a major ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=41...

Clinical Pharmacology & Therapeutics - Direct and rapid inhibition ...
Direct and rapid inhibition of factor Xa by otamixaban: A pharmacokinetic .... Roche Diagnostics, Mannheim, Germany) and stool (Hemoccult; Beckman Coulter, ...
http://www.nature.com/clpt/journal/v80/n6/full/clpt2006465a....

Rivaroxaban (BAY 59-7939) – an oral, direct Factor Xa inhibitor ...
Rivaroxaban inhibited Factor Xa activity by 35% and prolonged prothrombin time [by ... Roche, Grenzach-Wyhlen, Germany) and rivaroxaban in healthy subjects. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22...

Factor Xa inhibitors – a review of the recent patent literature ...
reports in the field of factor Xa inhibitors published between .... Mannheim/Roche Diagnostics described. analogs of DX-9065a, which contain the ...
http://www.biomedcentral.com/content/pdf/cd-392335.pdf...

Factor Xa Stimulates Proinflammatory and Profibrotic Responses in ...
Blots were imaged using Lumilight Plus ECL substrate from Roche (Basel, ..... Factor Xa stimulates fibroblast procollagen production, proliferation, ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=23...

: Article : Nature Reviews Drug Discovery
First experience with direct factor Xa inhibition in patients with stable coronary ... Roche et al. developed a virtual-screening method for predicting hERG ...
http://www.nature.com/nrd/journal/v1/n6/full/nrd830.html...

The Mitochondrial Message-specific mRNA Protectors Cbp1 and Pet309 ...
Proteins purified on Streptavidin beads and eluted with Factor Xa protease were separated by 7.5% SDS-PAGE. The gels were silver stained as described by ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=42...

Clinical Pharmacology & Therapeutics - Safety ...
Correlation between plasma concentration of BAY 59-7939 and factor Xa (FXa) inhibition (A) and PT (B). Full figure and legend (173 K ). Top of page ...
http://www.nature.com/clpt/journal/v78/n4/full/clpt2005511a....

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.